U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H40N4O9S
Molecular Weight 584.682
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SAMPATRILAT

SMILES

CS(=O)(=O)N[C@@H](CCCCN)C(=O)NC[C@H](CC1(CCCC1)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(O)=O)C(O)=O

InChI

InChIKey=LPUDGHQMOAHMMF-JBACZVJFSA-N
InChI=1S/C26H40N4O9S/c1-40(38,39)30-20(6-2-5-13-27)22(32)28-16-18(23(33)34)15-26(11-3-4-12-26)25(37)29-21(24(35)36)14-17-7-9-19(31)10-8-17/h7-10,18,20-21,30-31H,2-6,11-16,27H2,1H3,(H,28,32)(H,29,37)(H,33,34)(H,35,36)/t18-,20-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C26H40N4O9S
Molecular Weight 584.682
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Sampatrilat (also known as UK 81252) was developed as a dual inhibitor of both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). This drug was studied for the treatment of hypertension and congestive heart failure.

Approval Year

PubMed

PubMed

TitleDatePubMed
Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor I: assay in plasma of human volunteers by atmospheric-pressure ionisation mass-spectrometry following derivatisation with BF3-methanol.
1998 Jan
Patents

Patents

Sample Use Guides

After a 4-week placebo run-in period, 124 patients with a mean blood pressure of 162/102 mm Hg were randomized in a double-blind parallel-group design to 1 of 5 treatments, given once daily for 10 days: 50 mg, 100 mg, or 200 mg sampatrilat
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:23:09 GMT 2023
Edited
by admin
on Sat Dec 16 16:23:09 GMT 2023
Record UNII
V7O29949TG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SAMPATRILAT
INN   MI   WHO-DD  
INN  
Official Name English
Sampatrilat [WHO-DD]
Common Name English
sampatrilat [INN]
Common Name English
N-((1-((S)-3-((S)-6-AMINO-2-METHANESULFONAMIDOHEXANAMIDO)-2-CARBOXYPROPYL)CYCLOPENTYL)CARBONYL)-L-TYROSINE
Systematic Name English
UK-81,252
Code English
L-TYROSINE, N2-(METHYLSULFONYL)-L-LYSYL-1-((2S)-3-AMINO-2-CARBOXYPROPYL)CYCLOPENTANECARBONYL-
Systematic Name English
SAMPATRILAT [MI]
Common Name English
UK-81252
Code English
Classification Tree Code System Code
NCI_THESAURUS C247
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
Code System Code Type Description
MERCK INDEX
m9759
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY Merck Index
SMS_ID
100000084070
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
EVMPD
SUB10438MIG
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
CAS
129981-36-8
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
PUBCHEM
6324648
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
NCI_THESAURUS
C132269
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
FDA UNII
V7O29949TG
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
ChEMBL
CHEMBL42583
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
INN
7451
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
EPA CompTox
DTXSID6057877
Created by admin on Sat Dec 16 16:23:09 GMT 2023 , Edited by admin on Sat Dec 16 16:23:09 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY